AAPL vs. JNJ: Apple vs. Johnson & Johnson Stock Comparison
How do Apple (AAPL) and Johnson & Johnson (JNJ) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AAPL | JNJ |
|---|---|---|
| Name | Apple Inc. | Johnson & Johnson |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 4,975.38 billion USD | 664.95 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 12, 1980 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Total Return (1Y) | 31.02% | 53.82% |
| Total Return (3Y, Annualized) | 24.87% | 27.51% |
| Total Return (5Y, Annualized) | 18.93% | 14.71% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Volatility (1Y, Annualized) | 24.99% | 21.23% |
| Beta (5Y) | 1.08 | 0.21 |
| Max Drawdown (5Y) | -33.36% | -18.41% |
| Avg. Volume (3M) | 42.44M | 6.93M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Sharpe Ratio (1Y) | 1.07 | 2.33 |
| Sortino Ratio (1Y) | 1.58 | 3.66 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but Apple (AAPL) at 142.26% is the standout with ROE above its industry range; Johnson & Johnson (JNJ) at 20.02% also sits in the top quartile.
AAPL
Technology Hardware & Equipment industry group
142.26%
- AAPL
- 142.26%
- Max
- 42.47%
- Q3
- 19.13%
- Median
- 11.00%
- Q1
- 1.63%
- Min
- -20.62%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
20.02%
- Max
- 109.18%
- JNJ
- 20.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
For every dollar of sales, both Apple (AAPL) at 27.60% and Johnson & Johnson (JNJ) at 16.20% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
AAPL
Technology Hardware & Equipment industry group
27.60%
- AAPL
- 27.60%
- Max
- 27.60%
- Q3
- 11.66%
- Median
- 4.08%
- Q1
- 0.00%
- Min
- -11.02%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
16.20%
- Max
- 18.05%
- JNJ
- 16.20%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Both Apple (AAPL) at 31.13% and Johnson & Johnson (JNJ) at 25.74% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AAPL
Technology Hardware & Equipment industry group
31.13%
- Max
- 36.27%
- AAPL
- 31.13%
- Q3
- 18.36%
- Median
- 8.84%
- Q1
- 1.46%
- Min
- -21.39%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
25.74%
- Max
- 83.12%
- JNJ
- 25.74%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| ROE (TTM) | 142.26% | 20.02% |
| ROA (TTM) | 25.87% | 8.46% |
| Net Margin (TTM) | 27.60% | 16.20% |
| Operating Margin (TTM) | 31.13% | 25.74% |
| Gross Margin (TTM) | 48.79% | 67.78% |
Growth
Revenue Growth
Both Apple (AAPL) at 15.06% and Johnson & Johnson (JNJ) at 6.05% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Apple (AAPL) at 20.38% is closer to the peer norm — faster per-share earnings growth for JNJ.
Growth Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Revenue Growth (YoY) | 15.06% | 6.05% |
| Revenue Growth (3Y CAGR) | 7.70% | 5.60% |
| EPS Growth (YoY) | 20.38% | 90.50% |
| EPS Growth (3Y CAGR) | 13.57% | 17.90% |
Financial Strength
Current Ratio (MRQ)
Both Apple (AAPL) at 1.02 and Johnson & Johnson (JNJ) at 1.02 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AAPL
Technology Hardware & Equipment industry group
1.02
- Max
- 5.34
- Q3
- 3.02
- Median
- 1.95
- Q1
- 1.32
- AAPL
- 1.02
- Min
- 0.17
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.02
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- JNJ
- 1.02
- Min
- 0.10
Debt / Equity (MRQ)
Johnson & Johnson (JNJ) at 0.55 carries an industry-typical debt-to-equity mix, while Apple (AAPL) at 0.84 uses more debt funding than most peers.
AAPL
Technology Hardware & Equipment industry group
0.84
- Max
- 1.76
- AAPL
- 0.84
- Q3
- 0.78
- Median
- 0.24
- Q1
- 0.04
- Min
- 0.01
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.55
- Max
- 1.42
- Q3
- 0.65
- JNJ
- 0.55
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 1.02 | 1.02 |
| Debt / Equity (MRQ) | 0.84 | 0.55 |
| Net Debt / EBITDA | 0.22 | 0.79 |
Dividends
Dividend Yield (TTM)
Apple (AAPL) at 0.31% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
AAPL
Technology Hardware & Equipment industry group
0.31%
- Max
- 0.73%
- Q3
- 0.31%
- AAPL
- 0.31%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.94%
- JNJ
- 1.94%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Apple (AAPL) at 11.80% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.
AAPL
Technology Hardware & Equipment industry group
11.80%
- Max
- 32.27%
- Q3
- 14.48%
- AAPL
- 11.80%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
80.12%
- JNJ
- 80.12%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 0.31% | 1.94% |
| Dividend Payout Ratio (TTM) | 11.80% | 80.12% |
Valuation
P/E Ratio (TTM)
Both Apple (AAPL) at 38.13 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AAPL
Technology Hardware & Equipment industry group
38.13
- Max
- 69.48
- Q3
- 41.02
- AAPL
- 38.13
- Median
- 26.39
- Q1
- 19.36
- Min
- 6.07
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
41.92
- Max
- 85.34
- Q3
- 43.46
- JNJ
- 41.92
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Apple (AAPL) at 10.39 sits in the pricier quartile — AAPL costs more per dollar of sales.
AAPL
Technology Hardware & Equipment industry group
10.39
- Max
- 11.30
- AAPL
- 10.39
- Q3
- 5.82
- Median
- 2.56
- Q1
- 1.05
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.69
- Max
- 58.18
- Q3
- 25.77
- Median
- 7.30
- JNJ
- 6.69
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Both look rich against book: Johnson & Johnson (JNJ) at 8.16 sits in the upper P/B ratio quartile, and Apple (AAPL) at 44.39 prices even higher, above its industry range.
AAPL
Technology Hardware & Equipment industry group
44.39
- AAPL
- 44.39
- Max
- 10.75
- Q3
- 5.52
- Median
- 3.17
- Q1
- 1.79
- Min
- 0.33
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
8.16
- Max
- 13.53
- JNJ
- 8.16
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| P/E Ratio (TTM) | 38.13 | 41.92 |
| P/S Ratio (TTM) | 10.39 | 6.69 |
| P/B Ratio (MRQ) | 44.39 | 8.16 |
| Free Cash Flow Yield (TTM) | 2.12% | 2.78% |